| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8777894 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2018 | 7 Pages |
Abstract
Conservative management of CIN2 appears reasonable and safe in women under the age of 30 years, with 57% showing regression to negative cytology. There is a significant time lag before cytology becomes negative, so early recourse to treatment based on cytology alone is not advised where colposcopy is satisfactory and reassuring.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Michelle A.L. Godfrey, Manolis Nikolopoulos, Jessica E. Garner, Tania R. Adib, Debjani Mukhopadhyay, Jane S. Rains, Charlotte A. Harper, Rekha Wuntakal,